Brief: Zymeworks Q3 Pretax Profit USD -29.624 Million
31/10/2024 20:05
Oct 31 (Reuters) - Zymeworks Q3 operating expenses USD 50.205 million. * Q3 income from operations USD -34.205 million
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug